Skip to main content
SpringerLink
Log in

Impulse Control Disorder Behaviors Associated with Pramipexole Used to Treat Fibromyalgia

  • Original Paper
  • Published:
Journal of Gambling Studies Aims and scope Submit manuscript

Abstract

Objective: Compulsivity has been associated with use of dopamine agonists used to treat Parkinson’s disease (PD). Increasing use of these agents to treat fibromyalgia (FM) raises concern for this unexpected toxicity in a new group of patients. This is the first report of compulsive gambling and shopping among patients taking dopamine agonists for treatment of FM. Design: A retrospective chart review of all patients in a large, active FM research practice was used to identify compulsivity associated with dopamine agonists and describe its remission following dug withdrawal. Results: Of 3006 patients with FM treated between 2002 and 2006, 1356 had taken ≥1 dose of a dopamine agonist ( >95% pramipexole). Twenty-one (3 male, 18 female) were identified with compulsive gambling (33%), shopping (40%) or both (27%) after taking a 4.5 mg mean dose of pramipexole at bedtime for 14.4 ± 14.9 months. Compulsivity resolved in 3–10 days for 19 of 21 patients and by 3 months for all following a monitored, compulsory tapered discontinuation over 7 days. Conclusions: While biologic aspects of PD and FM differ considerably, compulsive gambling and shopping have become important, yet unexpected concerns related to use of dopamine agonists for patients with FM and their treating clinicians.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Aiken, C. B. (2007). Pramipexole in psychiatry: A systemic review of the literature. The Journal of Clinical Psychiatry, 68(8), 1230–1236.

    Article  PubMed  CAS  Google Scholar 

  • Carville, S. F., Arendt-Nielsen, S., Bliddal, H., Blotman, F., Branco, J. C., Buskila, D., et al. (2008). EULAR evidenced based recommendations for the management of fibromyalgia syndrome. Annals of the Rheumatic Diseases, 67(4), 536–541. doi:10.1136/ard.2007.071522.

    Article  PubMed  CAS  Google Scholar 

  • da Silva Lobo, D. S., Vallada, H. P., Knight, J., et al. (2007). Dopamine genes and pathological gambling in discordant sib-pairs. Journal of Gambling Studies, 23(4), 421–433. doi:10.1007/s10899-007-9060-x.

    Article  PubMed  Google Scholar 

  • Dodd, M. L., Klos, K. J., Bower, J. H., Geda, Y. E., Josephs, K. A., & Ahlskog, J. E. (2005). Pathological gambling caused by drugs used to treat Parkinson’s disease. Archives of Neurology, 62, 1–5. doi:10.1001/archneur.62.9.noc50009.

    Article  Google Scholar 

  • Evans, A. H., & Butzkueven, H. (2007). Dopamine agonist-induced pathological gambling in restless legs syndrome due to multiple sclerosis. Movement Disorders, 22(4), 590–591. doi:10.1002/mds.21303.

    Article  PubMed  Google Scholar 

  • Gallagher, D. A., O’Sullivan, S. S., Evans, A. H., Lees, A. J., & Schrag, A. (2007). Pathological gambling in Parkinson’s disease: Risk factors and differences from dopamine dysregulation. An analysis of published case series. Movement Disorders, 22(12), 1757–1763. doi:10.1002/mds.21611.

    Article  PubMed  Google Scholar 

  • Grant, J. E. (2008). Impulse control disorders: A clinician’s guide to understanding and treating behavioral addictions. New York: WW Norton.

    Google Scholar 

  • Grosset, K. A., Macphee, G., Pal, G., et al. (2006). Problematic gambling on dopamine agonists: Not such a rarity. Movement Disorders, 21(12), 2206–2208. doi:10.1002/mds.21110.

    Article  PubMed  Google Scholar 

  • Holman, A. J. (2003a). Ropinirole, a dopamine agonist, for refractory fibromyalgia: Preliminary observations. Journal of Clinical Rheumatology; Practical Reports on Rheumatic & Musculoskeletal Diseases, 9(4), 277–279. doi:10.1097/01.rhu.0000081264.26484.e5.

    Google Scholar 

  • Holman, A. J. (2003b). Pramipexole and fibromyalgia: Promise and precaution. Journal of Rheumatology, 30(12), 2733. letter.

    PubMed  Google Scholar 

  • Holman, A. J. (2004). Treatment of fibromyalgia with the dopamine agonist ropinirole a 14-week double-blind, pilot, randomized controlled trial with 14-week blinded extension. Arthritis and Rheumatism, 50(9), S698. abstract.

    Google Scholar 

  • Holman, A. J., & Myers, R. R. (2005). A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications. Arthritis and Rheumatism, 52(8), 2495–2505. doi:10.1002/art.21191.

    Article  PubMed  CAS  Google Scholar 

  • Holman, A. J., Neiman, R. A., & Ettlinger, R. E. (2004). Preliminary efficacy of the dopamine against, pramipexole for fibromyalgia: The first, open label, multicenter experience. Journal of Musculoskeletal Pain, 12(1), 69–74. doi:10.1300/J094v12n01_10.

    Article  Google Scholar 

  • Mamikonyan, E., Siderowf, A. D., Duda, J. E., Potenza, M. N., Horn, S., Stern, M. B., et al. (2008). Long-term follow-up of impulse control disorders in Parkinson’s disease. Movement Disorders, 23(1), 75–80. doi:10.1002/mds.21770.

    Article  PubMed  Google Scholar 

  • McIntyre, R. S., McElroy, S. L., Konarski, J. Z., Soczynska, J. K., Wilkins, K., & Kennedy, S. H. (2007). Problem gambling in bipolar disorder: Results of the Canadian Community Health Survey. Journal of Affective Disorders, 102(1–3), 27–34. doi:10.1016/j.jad.2006.12.005.

    Article  PubMed  Google Scholar 

  • Ondo, W. G., & Lai, D. (2008). Predictors of impulsivity and reward seeking behavior with dopamine agonists. Parkinsonism & Related Disorders, 14(1), 28–32. doi:10.1016/j.parkreldis.2007.05.006.

    Article  Google Scholar 

  • Quickfall, J., & Suchowersky, O. (2007). Pathological gambling associated with dopamine agonist use in restless legs syndrome. Parkinsonism & Related Disorders, 13(8), 535–536. doi:10.1016/j.parkreldis.2006.10.001.

    Article  Google Scholar 

  • Singh, A., Kandimala, G., Dewey, R. B., Jr, & O’Suilleabhain, P. (2007). Risk factors for pathological gambling and other compulsions among Parkinson’s disease patients taking dopamine agonists. Journal of Clinical Neuroscience, 14(12), 1178–1181. doi:10.1016/j.jocn.2007.01.009.

    Article  PubMed  CAS  Google Scholar 

  • Wood, P. B. (2004). Stress and dopamine: Implications for the pathophysiology of chronic widespread pain. Medical Hypotheses, 62, 420–424. doi:10.1016/j.mehy.2003.10.013.

    Article  PubMed  CAS  Google Scholar 

  • Wood, P. B. (2006). Mesolimbic dopaminergic mechanisms and pain control. Pain, 120, 230–234. doi:10.1016/j.pain.2005.12.014.

    Article  PubMed  CAS  Google Scholar 

  • Wood, P. B., Patterson, J. C., Sunderland, J. J., Tainter, J. H., Glabus, M. F., & Lilien, D. L. (2007). Reduced presynaptic dopamine activity in fibromyalgia syndrome demonstrated with positron emission tomography: A pilot study. Pain, 8(1), 51–58. doi:10.1016/j.jpain.2006.05.014.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pacific Rheumatology Research, 4300 Talbot Road South, Suite 101, Renton, WA, 98055, USA

    Andrew J. Holman

Authors
  1. Andrew J. Holman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrew J. Holman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Holman, A.J. Impulse Control Disorder Behaviors Associated with Pramipexole Used to Treat Fibromyalgia. J Gambl Stud 25, 425–431 (2009). https://doi.org/10.1007/s10899-009-9123-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10899-009-9123-2

Keywords

Search

Navigation